Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

Knowing your family history and symptoms to watch for can help ensure the disease is diagnosed as soon as possible ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Positive results in patients with advanced mCRC emphasize potential significance of CytoDyn’s ongoing Phase II CRC trial Dr. Benjamin Weinberg to present final results at the ESMO Gastrointestinal ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

A new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights ...

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

According to Research by SNS Insider, the Gastrointestinal Endoscopic Devices Market growth is Driven by Advancements in minimally invasive procedures and increasing prevalence of gastrointestinal ...

Dr. Breelyn Wilky, director of sarcoma medical oncology at the University of Colorado Cancer Center, encourages patients with gastrointestinal stromal tumors (GIST) to seek expert care and stay ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

NHS FDP Cancer 360 dominated the headlines last month as Government announced it is to be rolled out across the NHS. Initially piloted at Chelsea and Westminster NHS Foundation Trust’s gynaecology ...